Peptidylprolyl Isomerase A (Cyclophilin A) (PPIA) Peptide
-
- Target See all PPIA products
- PPIA (Peptidylprolyl Isomerase A (Cyclophilin A) (PPIA))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- FRALSTGEKG FGYKGSCFHR IIPGFMCQGG DFTRHNGTGG KSIYGEKFED
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of PPIA antibody,
Alternative Names: PPIA control peptide, PPIA antibody Blocking Peptide, Anti-PPIA Blocking Peptide, Peptidylprolyl Isomerase A Blocking Peptide, Cyclophilin A Blocking Peptide, CYPA Blocking Peptide, CYPH Blocking Peptide, MGC117158 Blocking Peptide, MGC12404 Blocking Peptide, MGC23397 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- PPIA (Peptidylprolyl Isomerase A (Cyclophilin A) (PPIA))
- Background
- PPIA is a member of the peptidyl-prolyl cis-trans isomerase (PPIase) family. PPIases catalyze the cis-trans isomerization of proline imidic peptide bonds in oligopeptides and accelerate the folding of proteins. PPIA is a cyclosporin binding-protein and may play a role in cyclosporin A-mediated immunosuppression. The protein can also interact with several HIV proteins, including p55 gag, Vpr, and capsid protein, and has been shown to be necessary for the formation of infectious HIV virions.
- Molecular Weight
- 18 kDa
-